185 related articles for article (PubMed ID: 7252332)
1. Role of chemotactic factor inactivation in neutrophil chemotaxis.
Tannous R; Cavender-Zylich N; Ginsberg BH
J Lab Clin Med; 1981 Aug; 98(2):238-50. PubMed ID: 7252332
[TBL] [Abstract][Full Text] [Related]
2. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
Robbins RA; Hamel FG
J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
[TBL] [Abstract][Full Text] [Related]
3. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
[TBL] [Abstract][Full Text] [Related]
4. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid.
Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI
J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952
[TBL] [Abstract][Full Text] [Related]
5. Biochemical quantitation of the chemotactic factor inactivator activity in human serum.
Fantone J; Senior RM; Kreutzer DL; Jones M; Ward PA
J Lab Clin Med; 1979 Jan; 93(1):17-24. PubMed ID: 759526
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung.
Robbins RA; Gossman GL; Nelson KJ; Koyama S; Thompson AB; Rennard SI
Am Rev Respir Dis; 1990 Oct; 142(4):763-8. PubMed ID: 2221580
[TBL] [Abstract][Full Text] [Related]
7. Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
Hill HR; Bohnsack JF; Morris EZ; Augustine NH; Parker CJ; Cleary PP; Wu JT
J Immunol; 1988 Nov; 141(10):3551-6. PubMed ID: 3053900
[TBL] [Abstract][Full Text] [Related]
8. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
Shingu M; Nobunaga M
Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum chemotactic factor inactivator activity in rabbits induced by inflammation and chemotactic factor.
Hupp JR; Despins AW; McCormick JR; Armstrong G; Kreutzer DL
Am J Pathol; 1982 Dec; 109(3):277-82. PubMed ID: 7180941
[TBL] [Abstract][Full Text] [Related]
10. Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome.
Robbins R; Maunder R; Gossman G; Kendall T; Hudson L; Rennard S
Am Rev Respir Dis; 1990 Jun; 141(6):1463-8. PubMed ID: 2350087
[TBL] [Abstract][Full Text] [Related]
11. Decreased chemotactic activity in activated newborn plasma.
Tannous R; Spitzer RE; Clarke WR; Goplerud CP; Cavendar-Zylich N
J Lab Clin Med; 1982 Mar; 99(3):331-41. PubMed ID: 7057060
[TBL] [Abstract][Full Text] [Related]
12. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
13. Antileukotactic properties of tumor cells.
Brozna JP; Ward PA
J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
[TBL] [Abstract][Full Text] [Related]
14. Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis.
McCormick JR; Kreutzer DL; Keating HJ; Hupp J; Despins A; Moore M
Am J Pathol; 1982 Dec; 109(3):283-7. PubMed ID: 7180942
[TBL] [Abstract][Full Text] [Related]
15. Analysis of selected variables in the under-agarose assay for chemotactic responses of canine neutrophils.
Nagahata H; Kociba GJ; Reiter JA; Couto CG
Am J Vet Res; 1991 Jun; 52(6):965-9. PubMed ID: 1883103
[TBL] [Abstract][Full Text] [Related]
16. Elevation of serum chemotactic factor inactivator activity during acute inflammatory reactions in patients with hypersensitivity pneumonitis.
Kreutzer DL; McCormick JR; Thrall RS; Hupp JR; Moore VL; Fink JN
Am Rev Respir Dis; 1982 May; 125(5):612-4. PubMed ID: 7081823
[TBL] [Abstract][Full Text] [Related]
17. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis.
Matzner Y; Marx G; Drexler R; Eldor A
Thromb Haemost; 1984 Oct; 52(2):134-7. PubMed ID: 6084320
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
20. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
Goetzl EJ; Rocklin RE
J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
